Literature DB >> 16203481

The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list.

S J Adamson1, J D Sellman.   

Abstract

Sixty-four patients on the Christchurch Methadone Treatment Programme waiting list were questioned on their drug-use behaviour, criminal activity and sources of income, both legal and illegal, for the preceding 7 days. Opioids used included morphine sulphate tablets, methadone and opium poppies, while other drugs used included tranquillizers, cannabis and alcohol. A significant minority were prescribed opioids. The mean cost of drugs used in 7 days across all subjects was 882 dollars. The mean financial gain from criminal sources for the same period was 1079 dollars and was derived from drug-related crime, property crime and prostitution. Few gender differences were found relating to criminal activity or drug use. The majority of the sample were on unemployment benefits of varying types while a minority were in paid employment. Those in paid employment did not earn significantly less from criminal activity, nor did they spend significantly less on drug use than did those not in paid employment. An important implication of these findings is that untreated opioid users are a substantial financial burden to the community, strongly supporting the argument for greater treatment provision.

Entities:  

Year:  1998        PMID: 16203481     DOI: 10.1080/09595239800186961

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  8 in total

1.  Administrative, clinical, and ethical issues surrounding the use of waiting lists in the delivery of mental health services.

Authors:  Seth A Brown; Jefferson D Parker; Phillip R Godding
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  A brief telephone intervention targeting treatment engagement from a substance abuse program wait list.

Authors:  Jefferson D Parker; Cynthia L Turk; Lisa D Busby
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

3.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

4.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

5.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

6.  Wait times for publicly funded addiction and problem gambling treatment agencies in Ontario, Canada.

Authors:  Rachael V Pascoe; Brian Rush; Nooshin Khobzi Rotondi
Journal:  BMC Health Serv Res       Date:  2013-11-19       Impact factor: 2.655

Review 7.  Interim opioid agonist treatment for opioid addiction: a systematic review.

Authors:  Laura Samsó Jofra; Teresa Puig; Ivan Solà; Joan Trujols
Journal:  Harm Reduct J       Date:  2022-01-29

8.  Accounting for individual differences and timing of events: estimating the effect of treatment on criminal convictions in heroin users.

Authors:  Jo Røislien; Thomas Clausen; Jon Michael Gran; Anne Bukten
Journal:  BMC Med Res Methodol       Date:  2014-05-17       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.